Skip to main content
. Author manuscript; available in PMC: 2014 Jul 18.
Published in final edited form as: Vaccine. 2013 Jun 2;31(33):3320–3326. doi: 10.1016/j.vaccine.2013.05.077

Figure 2.

Figure 2

Titer of antigen specific IgG responses against rBmHAT, rBmHSP12.6, rBmALT-2 and rBmTSP-LEL were determined in the sera of (a) gerbils immunized with a 100 µg of pVAX-1 BmHAT DNA plus 15 µg of rBmHAT protein on the same day followed by L3 trickle infection (BmHAT DNA-protein L3 trickle), (b) gerbils immunized with 15 µg of rBmHAT protein followed by L3 trickle infection (BmHAT protein L3 trickle) and (c) control animals that received only the L3 trickle infection (L3 trickle only). Serum values from gerbils vaccinated with the traditional pVAX-1 BmHAT DNA prime followed by rBmHAT protein boost (BmHAT prime boost) was used as the positive controls and gerbils that received adjuvant alone remained as negative controls. Data is from one of two similar experiments. *P<0.05, **P<0.01 and ***P<0.001 compared to negative controls.